Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(17 sites)
United States
Arkansas Urology, Little Rock, Arkansas Tower Urology, Los Angeles, California Saint John's Cancer Institute, Santa Monica, California Montefiore Medical Center, The Bronx, New York Carolina Urologic Research Center, Myrtle Beach, South Carolina Urology Associates, P.C., Nashville, Tennessee Urology Clinics of North Texas, Dallas, Texas Baylor College of Medicine, Houston, Texas The University of Texas San Antonio, San Antonio, Texas Urology San Antonio/USA Clinical Trials, San Antonio, Texas The Urology Place, San Antonio, Texas Australia
Westmead Private Hospital, Westmead, New South Wales Austin Health, Heidelberg, Victoria Warringal Private Hospital, Heidelberg, Victoria Penninsula Private Hospital, Langwarrin, Victoria The Royal Melbourne Hospital, Parkville, Victoria Hollywood Private Hospital, Nedlands, Western Australia